HB Wealth Management’s Transmedics TMDX Stock Holding History

HB Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1M	Buy	15,062 +219	+1%	+$18.5K	0.01%	742
2026 Q1	$1.48M	Buy	14,843 +107	+0.7%	+$14K	0.01%	520
2025 Q4	$1.79M	Buy	14,736 +258	+2%	+$32.4K	0.01%	429
2025 Q3	$1.62M	Buy	14,478 +2,422	+20%	+$284K	0.01%	469
2025 Q2	$1.62M	Buy	12,056 +1,429	+13%	+$157K	0.01%	422
2025 Q1	$715K	Buy	10,627 +2,478	+30%	+$170K	0.01%	649
2024 Q4	$508K	Buy	8,149 +2,689	+49%	+$250K	0.01%	617
2024 Q3	$857K	Buy	5,460 +3,352	+159%	+$516K	0.01%	434
2024 Q2	$318K	Buy	+2,108	New	+$253K	﹤0.01%	696

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

HB Wealth Management's TMDX Position: Q2 2026 in Review

HB Wealth Management increased its Transmedics (TMDX) stake by 1.5% in Q2 2026, buying an estimated $18.5K and bringing the position to 15,062 shares worth $1M. The position accounts for 0.01% of the portfolio, ranked #742.

HB Wealth Management first reported a position in TMDX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.79M in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

HB Wealth Management held 15,062 shares of Transmedics worth $1M as of Q2 2026.
HB Wealth Management bought 219 Transmedics shares in Q2 2026, an estimated $18.5K.
Transmedics made up 0.01% of HB Wealth Management's portfolio in Q2 2026, its #742 holding.
HB Wealth Management first reported a position in Transmedics in Q2 2024 and has held it in 9 quarters since.
HB Wealth Management's Transmedics position peaked at $1.79M in Q4 2025.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.